Skip to main content
Log in

Six-year follow-up study of bone mineral density in patients with systemic lupus erythematosus

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

Long-term bone mineral density (BMD) changes and the associated factors in systemic lupus erythematosus (SLE) patients were assessed. Despite the remarkably low overall bone loss, significant spine bone loss was associated with the use of glucocorticoids, use of antimalarials, and lower 25-hydroxyvitamin D levels, stressing the importance of prevention of osteoporosis and vitamin D deficiency in SLE patients.

Introduction

The aim of this study is to assess the BMD changes in patients with SLE and to identify the associated factors.

Methods

Demographic and clinical data of 126 SLE patients were collected, and BMD measurements of the lumbar spine and the total hip were performed by dual-energy X-ray absorptiometry at baseline and follow-up. Statistical analyses were performed using independent Mann–Whitney U tests and linear regression analyses.

Results

At baseline, 39.7 % of the patients (90 % female, mean age 39 ± 12.2 years) had osteopenia, and 6.3 % had osteoporosis. The median follow-up duration was 6.7 years (range 1.9–9.3 years). Mean changes in BMD at the lumbar spine (−0.08 %/year) and the hip (−0.20 %/year) were not significant. During follow-up, 70 % of the patients used glucocorticoids. The mean ± SD daily glucocorticoid dose was 5.0 ± 5.0 mg. In multiple regression analysis, BMD loss at the spine was significantly associated with higher daily glucocorticoid dose and lower baseline 25-hydroxyvitamin D levels. BMD loss at the hip was associated with lower 25-hydroxyvitamin D levels at baseline, reduction of body mass index, and baseline use of antimalarials.

Conclusions

In this 6-year follow-up study, bone loss was remarkably low. A dose-dependent relationship between glucocorticoid use and spinal bone loss was found. In addition, the use of antimalarials and lower 25-hydroxyvitamin D levels at baseline were associated with BMD loss. These findings underline the importance of prevention and treatment of vitamin D deficiency and osteoporosis in SLE, especially in patients using glucocorticoids or antimalarials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, Urowitz M, Fortin PR, Petri M, Barr S, Gordon C, Bae SC, Isenberg D, Zoma A, Aranow C, Dooley MA, Nived O, Sturfelt G, Steinsson K, Alarcon G, Senecal JL, Zummer M, Hanly J, Ensworth S, Pope J, Edworthy S, Rahman A, Sibley J, El-Gabalawy H, McCarthy T, St PY, Clarke A, Ramsey-Goldman R (2006) Mortality in systemic lupus erythematosus. Arthritis Rheum 54:2550–2557

    Article  PubMed  CAS  Google Scholar 

  2. Almehed K, Forsblad d'Elia H, Kvist G, Ohlsson C, Carlsten H (2007) Prevalence and risk factors of osteoporosis in female SLE patients—extended report. Rheumatology (Oxford) 46:1185–1190

    Article  CAS  Google Scholar 

  3. Gilboe IM, Kvien TK, Haugeberg G, Husby G (2000) Bone mineral density in systemic lupus erythematosus: comparison with rheumatoid arthritis and healthy controls. Ann Rheum Dis 59:110–115

    Article  PubMed  CAS  Google Scholar 

  4. Yee CS, Crabtree N, Skan J, Amft N, Bowman S, Situnayake D, Gordon C (2005) Prevalence and predictors of fragility fractures in systemic lupus erythematosus. Ann Rheum Dis 64:111–113

    Article  PubMed  Google Scholar 

  5. Bhattoa HP, Bettembuk P, Balogh A, Szegedi G, Kiss E (2002) Bone mineral density in women with systemic lupus erythematosus. Clin Rheumatol 21:135–141

    Article  PubMed  CAS  Google Scholar 

  6. Bultink IE, Lems WF, Kostense PJ, Dijkmans BA, Voskuyl AE (2005) Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum 52:2044–2050

    Article  PubMed  Google Scholar 

  7. Lakshminarayanan S, Walsh S, Mohanraj M, Rothfield N (2001) Factors associated with low bone mineral density in female patients with systemic lupus erythematosus. J Rheumatol 28:102–108

    PubMed  CAS  Google Scholar 

  8. Mendoza-Pinto C, Garcia-Carrasco M, Sandoval-Cruz H, Escarcega RO, Jimenez-Hernandez M, Etchegaray-Morales I, Soto-Vega E, Munoz-Guarneros M, Lopez-Colombo A, eze-Hinojosa M, Cervera R (2009) Risks factors for low bone mineral density in pre-menopausal Mexican women with systemic lupus erythematosus. Clin Rheumatol 28:65–70

    Article  PubMed  Google Scholar 

  9. Becker A, Fischer R, Scherbaum WA, Schneider M (2001) Osteoporosis screening in systemic lupus erythematosus: impact of disease duration and organ damage. Lupus 10:809–814

    Article  PubMed  CAS  Google Scholar 

  10. Lee C, Almagor O, Dunlop DD, Manzi S, Spies S, Chadha AB, Ramsey-Goldman R (2006) Disease damage and low bone mineral density: an analysis of women with systemic lupus erythematosus ever and never receiving corticosteroids. Rheumatology (Oxford) 45:53–60

    Article  CAS  Google Scholar 

  11. Furukawa M, Kiyohara C, Tsukamoto H, Mitoma H, Kimoto Y, Uchino A, Nakagawa M, Oryoji K, Shimoda T, Akashi K, Harada M, Horiuchi T (2011) Prevalence of and risk factors for low bone mineral density in Japanese female patients with systemic lupus erythematosus. Rheumatol Int 31:365–376

    Article  PubMed  Google Scholar 

  12. Lee C, Almagor O, Dunlop DD, Chadha AB, Manzi S, Spies S, Ramsey-Goldman R (2007) Association between African American race/ethnicity and low bone mineral density in women with systemic lupus erythematosus. Arthritis Rheum 57:585–592

    Article  PubMed  Google Scholar 

  13. Huisman AM, White KP, Algra A, Harth M, Vieth R, Jacobs JW, Bijlsma JW, Bell DA (2001) Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol 28:2535–2539

    PubMed  CAS  Google Scholar 

  14. Mok CC, Mak A, Ma KM (2005) Bone mineral density in postmenopausal Chinese patients with systemic lupus erythematosus. Lupus 14:106–112

    Article  PubMed  CAS  Google Scholar 

  15. Mok CC, Ying SKY, To CH, Ma KM (2008) Bone mineral density and body composition in men with systemic lupus erythematosus: a case control study. Bone 43:327–331

    Article  PubMed  Google Scholar 

  16. Chong HC, Chee SS, Goh EM, Chow SK, Yeap SS (2007) Dietary calcium and bone mineral density in premenopausal women with systemic lupus erythematosus. Clin Rheumatol 26:182–185

    Article  PubMed  CAS  Google Scholar 

  17. Kipen Y, Buchbinder R, Forbes A, Strauss B, Littlejohn G, Morand E (1997) Prevalence of reduced bone mineral density in systemic lupus erythematosus and the role of steroids. J Rheumatol 24:1922–1929

    PubMed  CAS  Google Scholar 

  18. Boyanov M, Robeva R, Popivanov P (2003) Bone mineral density changes in women with systemic lupus erythematosus. Clin Rheumatol 22:318–323

    Article  PubMed  CAS  Google Scholar 

  19. Jardinet D, Lefebvre C, Depresseux G, Lambert M, Devogelaer JP, Houssiau FA (2000) Longitudinal analysis of bone mineral density in pre-menopausal female systemic lupus erythematosus patients: deleterious role of glucocorticoid therapy at the lumbar spine. Rheumatology (Oxford) 39:389–392

    Article  CAS  Google Scholar 

  20. Kipen Y, Briganti E, Strauss B, Will R, Littlejohn G, Morand E (1999) Three year followup of bone mineral density change in premenopausal women with systemic lupus erythematosus. J Rheumatol 26:310–317

    PubMed  CAS  Google Scholar 

  21. Hansen M, Halberg P, Kollerup G, Pedersen-Zbinden B, Horslev-Petersen K, Hyldstrup L, Lorenzen I (1998) Bone metabolism in patients with systemic lupus erythematosus. Effect of disease activity and glucocorticoid treatment. Scand J Rheumatol 27:197–206

    Article  PubMed  CAS  Google Scholar 

  22. Pons F, Peris P, Guanabens N, Font J, Huguet M, Espinosa G, Ingelmo M, Munoz-Gomez J, Setoain J (1995) The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in pre-menopausal women. Br J Rheumatol 34:742–746

    Article  PubMed  CAS  Google Scholar 

  23. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725

    Article  PubMed  CAS  Google Scholar 

  24. Lips P (2007) Relative value of 25(OH)D and 1,25(OH)2D measurements. J Bone Miner Res 22:1668–1671

    Article  PubMed  CAS  Google Scholar 

  25. Natsui K, Tanaka K, Suda M, Yasoda A, Sakuma Y, Ozasa A, Ozaki S, Nakao K (2006) High-dose glucocorticoid treatment induces rapid loss of trabecular bone mineral density and lean body mass. Osteoporos Int 17:105–108

    Article  PubMed  CAS  Google Scholar 

  26. Ruiz-Irastorza G, Egurbide MV, Olivares N, Martinez-Berriotxoa A, Aguirre C (2008) Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology 47:920–923

    Article  PubMed  CAS  Google Scholar 

  27. Toloza SMA, Cole DEC, Gladman DD, Ibanez D, Urowitz MB (2010) Vitamin D insufficiency in a large female SLE cohort. Lupus 19:13–19

    Article  PubMed  CAS  Google Scholar 

  28. Stockton KA, Mengersen K, Paratz JD, Kandiah D, Bennell KL (2011) Effect of vitamin D supplementation on muscle strength: a systematic review and meta-analysis. Osteoporos Int 22:859–871

    PubMed  CAS  Google Scholar 

  29. Flicker L, Mead K, MacInnis RJ, Nowson C, Scherer S, Stein MS, Thomasx J, Hopper JL, Wark JD (2003) Serum vitamin D and falls in older women in residential care in Australia. J Am Geriatr Soc 51:1533–1538

    Article  PubMed  Google Scholar 

  30. Snijder MB, van Schoor NM, Pluijm SM, van Dam RM, Visser M, Lips P (2006) Vitamin D status in relation to one-year risk of recurrent falling in older men and women. J Clin Endocrinol Metab 91:2980–2985

    Article  PubMed  CAS  Google Scholar 

  31. Adams JS, Diz MM, Sharma OP (1989) Effective reduction in the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia with short-course chloroquine therapy. Ann Intern Med 111:437–438

    Article  PubMed  CAS  Google Scholar 

  32. Bijlsma JW, Boers M, Saag KG, Furst DE (2003) Glucocorticoids in the treatment of early and late RA. Ann Rheum Dis 62:1033–1037

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to I. E. M. Bultink.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jacobs, J., Korswagen, LA., Schilder, A.M. et al. Six-year follow-up study of bone mineral density in patients with systemic lupus erythematosus. Osteoporos Int 24, 1827–1833 (2013). https://doi.org/10.1007/s00198-012-2157-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-012-2157-9

Keywords

Navigation